| P2093 | author name string | Lin Wang | |
| | Jin Wang | |
| | Qian Ran | |
| | Hai-Rong Zeng | |
| | Qin-Wan Huang | |
| | Xiang-Bo Yang | |
| P2860 | cites work | Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes | Q24309211 |
| | Insulin and insulin resistance. | Q24532776 |
| | The antihyperglycemic effects of Rhizoma Coptidis and mechanism of actions: a review of systematic reviews and pharmacological research | Q26851917 |
| | Rhizoma Coptidis: A Potential Cardiovascular Protective Agent | Q28067054 |
| | San-Huang-Xie-Xin-Tang Constituents Exert Drug-Drug Interaction of Mutual Reinforcement at Both Pharmacodynamics and Pharmacokinetic Level: A Review | Q28075782 |
| | The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes | Q28273497 |
| | Endothelial nitric oxide synthase in vascular disease: from marvel to menace | Q28305279 |
| | Berberine Improves Glucose Metabolism in Diabetic Rats by Inhibition of Hepatic Gluconeogenesis | Q28477076 |
| | Berberine promotes glucose consumption independently of AMP-activated protein kinase activation | Q28541332 |
| | Berberine attenuates podocytes injury caused by exosomes derived from high glucose-induced mesangial cells through TGFβ1-PI3K/AKT pathway | Q49602918 |
| | The protection of resveratrol and its combination with glibenclamide, but not berberine on the diabetic hearts against reperfusion-induced arrhythmias: the role of myocardial KATP channel. | Q49853562 |
| | Tackling dipeptidyl peptidase IV in neurological disorders | Q49940117 |
| | Effects of palmatine on rats with comorbidity of diabetic neuropathic pain and depression | Q50049980 |
| | Berberine Ameliorates Diabetic Neuropathy: TRPV1 Modulation by PKC Pathway | Q50089534 |
| | Effects of berberine on mRNA expression levels of PPARγ and adipocytokines in insulin-resistant adipocytes | Q50124025 |
| | Regulations of berberine on gene expression of BMP4 transcriptional pathways to improve visceral white adipose tissues insulin resistance in type 2 diabetic hamsters | Q50226747 |
| | Berberine reduced blood pressure and improved vasodilation in diabetic rats | Q50640205 |
| | Berberine chloride improved synaptic plasticity in STZ induced diabetic rats. | Q50746082 |
| | Runx2 Controls Bone Resorption through the Down-Regulation of the Wnt Pathway in Osteoblasts. | Q50908319 |
| | Effects of type 2 diabetes mellitus on the pharmacokinetics of berberine in rats | Q51019283 |
| | An activity-integrated strategy involving ultra-high-performance liquid chromatography/quadrupole-time-of-flight mass spectrometry and fraction collector for rapid screening and characterization of the α-glucosidase inhibitors in Coptis chinensis Fr | Q51062237 |
| | Berberine exerts renoprotective effects by regulating the AGEs-RAGE signaling pathway in mesangial cells during diabetic nephropathy | Q51191631 |
| | Berberine regulates glycemia via local inhibition of intestinal dipeptidyl peptidase-Ⅳ | Q51273832 |
| | Berberine elicits anti-arrhythmic effects via IK1/Kir2.1 in the rat type 2 diabetic myocardial infarction model | Q84561983 |
| | Cytotoxicity and antihyperglycemic effect of minor constituents from Rhizoma Coptis in HepG2 cells | Q85035223 |
| | Protein tyrosine phosphatase 1B inhibitory activity of alkaloids from Rhizoma Coptidis and their molecular docking studies | Q85263601 |
| | Screening for potential -α -Glucosidase inhibitors in Coptis chinensis franch extract using ultrafiltration LC-ESI-MSn | Q86023429 |
| | Propionic and butyric acids, formed in the caecum of rats fed highly fermentable dietary fibre, are reflected in portal and aortic serum | Q86493364 |
| | Renoprotective effects of berberine and its potential effect on the expression of β-arrestins and intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in streptozocin-diabetic nephropathy rats | Q86619116 |
| | Renoprotective effect of berberine on type 2 diabetic nephropathy in rats | Q87103959 |
| | Berberine regulates the expression of E-prostanoid receptors in diabetic rats with nephropathy | Q87216947 |
| | Berberine reduces ischemia/reperfusion-induced myocardial apoptosis via activating AMPK and PI3K-Akt signaling in diabetic rats | Q87512678 |
| | The renoprotective effects of berberine via the EP4-Gαs-cAMP signaling pathway in different stages of diabetes in rats | Q87923423 |
| | Ameliorating effect of berbamine on hepatic key enzymes of carbohydrate metabolism in high-fat diet and streptozotocin induced type 2 diabetic rats | Q88423165 |
| | [Hypolipidemic effect of Coptis chinensis and C. deltoidea on type 2 diabetes rats through SCAP/SREBP-1c signal pathway] | Q89201578 |
| | Diabetic dyslipidaemia | Q89261937 |
| | Antifibrotic cardioprotection of berberine via downregulating myocardial IGF-1 receptor-regulated MMP-2/MMP-9 expression in diabetic rats | Q89342699 |
| | Attenuation of type-1 diabetes-induced cardiovascular dysfunctions by direct thrombin inhibitor in rats: a mechanistic study | Q89414548 |
| | Dietary polyphenols and type 2 diabetes: Human Study and Clinical Trial | Q89546796 |
| | Treatment with crocin improves cardiac dysfunction by normalizing autophagy and inhibiting apoptosis in STZ-induced diabetic cardiomyopathy | Q90288268 |
| | Berberine promotes glucose uptake and inhibits gluconeogenesis by inhibiting deacetylase SIRT3 | Q90995304 |
| | DPP-4 inhibitors promote proliferation and migration of rat brain microvascular endothelial cells under hypoxic/high-glucose conditions, potentially through the SIRT1/HIF-1/VEGF pathway | Q91095879 |
| | Berberine Alleviates Tau Hyperphosphorylation and Axonopathy-Associated with Diabetic Encephalopathy via Restoring PI3K/Akt/GSK3β Pathway | Q91270835 |
| | Possible therapeutic potential of berberine in the treatment of STZ plus HFD-induced diabetic osteoporosis | Q91484775 |
| | Different structures of berberine and five other protoberberine alkaloids that affect P-glycoprotein-mediated efflux capacity | Q93161669 |
| | Tetrahydroxy stilbene glucoside protected against diabetes-induced osteoporosis in mice with streptozotocin-induced hyperglycemia | Q93233158 |
| | Anti-diabetic property of Tinospora cordifolia and its active compound is mediated through the expression of Glut-4 in L6 myotubes | Q95481807 |
| | Hypoglycemic activity of alkaloidal fraction of Tinospora cordifolia | Q39526185 |
| | Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression | Q39792130 |
| | Berberine prevents hyperglycemia-induced endothelial injury and enhances vasodilatation via adenosine monophosphate-activated protein kinase and endothelial nitric oxide synthase. | Q39878461 |
| | Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression | Q39908313 |
| | Coptidis rhizoma extract protects against cytokine-induced death of pancreatic beta-cells through suppression of NF-kappaB activation | Q40140380 |
| | Effect of berberrubine on interleukin-8 and monocyte chemotactic protein-1 expression in human retinal pigment epithelial cell line | Q40263277 |
| | Protective effect of Coptidis Rhizoma on S-nitroso-N-acetylpenicillamine (SNAP)-induced apoptosis and necrosis in pancreatic RINm5F cells. | Q40482420 |
| | Myocardial Salvaging Effects of Berberine in Experimental Diabetes Co-Existing with Myocardial Infarction | Q40571635 |
| | Effects of pioglitazone and fenofibrate co-administration on bone biomechanics and histomorphometry in ovariectomized rats | Q41656785 |
| | Effects of berberine on amelioration of hyperglycemia and oxidative stress in high glucose and high fat diet-induced diabetic hamsters in vivo | Q41841136 |
| | Curcumin ameliorates macrophage infiltration by inhibiting NF-κB activation and proinflammatory cytokines in streptozotocin induced-diabetic nephropathy. | Q41854992 |
| | RAGE-Mediated Inflammation, Type 2 Diabetes, and Diabetic Vascular Complication | Q41932557 |
| | Inhibition of advanced glycation and absence of galectin-3 prevent blood-retinal barrier dysfunction during short-term diabetes. | Q42767408 |
| | Coptis chinensis alkaloids exert anti-adipogenic activity on 3T3-L1 adipocytes by downregulating C/EBP-α and PPAR-γ. | Q42797989 |
| | The inhibiting effect of the Coptis chinensis polysaccharide on the type II diabetic mice | Q42810100 |
| | Berberine regulates peroxisome proliferator-activated receptors and positive transcription elongation factor b expression in diabetic adipocytes | Q42820205 |
| | Protective effect of berberine on renal fibrosis caused by diabetic nephropathy | Q42835125 |
| | Berberine ameliorates renal injury in diabetic C57BL/6 mice: Involvement of suppression of SphK-S1P signaling pathway | Q42963879 |
| | Berberine suppresses intestinal disaccharidases with beneficial metabolic effects in diabetic states, evidences from in vivo and in vitro study | Q43129958 |
| | Increased plasma exposures of five protoberberine alkaloids from Coptidis Rhizoma in streptozotocin-induced diabetic rats: is P-GP involved? | Q43182248 |
| | Ameliorative effect of berberine on endothelial dysfunction in diabetic rats induced by high-fat diet and streptozotocin | Q43290690 |
| | Mechanisms of modified LDL-induced pericyte loss and retinal injury in diabetic retinopathy | Q43442147 |
| | Alteration of the intestinal barrier and GLP2 secretion in Berberine-treated type 2 diabetic rats | Q43635628 |
| | Berberine suppresses high glucose-induced TGF-β1 and fibronectin synthesis in mesangial cells through inhibition of sphingosine kinase 1/AP-1 pathway | Q44036628 |
| | The involvement of P-glycoprotein in berberine absorption | Q44279883 |
| | Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction | Q44304785 |
| | Hippocampal synaptic plasticity restoration and anti-apoptotic effect underlie berberine improvement of learning and memory in streptozotocin-diabetic rats | Q44331287 |
| | Impaired gastric emptying and altered intragastric meal distribution in diabetes mellitus related to autonomic neuropathy? | Q44488564 |
| | Berberine attenuates high glucose-induced proliferation and extracellular matrix accumulation in mesangial cells: involvement of suppression of cell cycle progression and NF-κB/AP-1 pathways | Q44578386 |
| | Synthesis, activity, and molecular modeling studies of novel human aldose reductase inhibitors based on a marine natural product | Q44652622 |
| | Accelerated nephropathy in diabetic apolipoprotein e-knockout mouse: role of advanced glycation end products. | Q45000524 |
| | The anti-diabetic effects and pharmacokinetic profiles of berberine in mice treated with Jiao-Tai-Wan and its compatibility | Q45265855 |
| | Effects of berberine on expression of hepatocyte nuclear factor 4alpha and glucokinase activity in mouse primary hepatocytes | Q46152611 |
| | Berberine reduces fibronectin and collagen accumulation in rat glomerular mesangial cells cultured under high glucose condition | Q46163975 |
| | Anti-diabetic effects of cinnamaldehyde and berberine and their impacts on retinol-binding protein 4 expression in rats with type 2 diabetes mellitus. | Q46199809 |
| | Inhibitory activities of the alkaloids from Coptidis Rhizoma against aldose reductase | Q46235160 |
| | Berberine ameliorates experimental diabetes-induced renal inflammation and fibronectin by inhibiting the activation of RhoA/ROCK signaling | Q46480430 |
| | Antihyperglycemia and Antihyperlipidemia Effect of Protoberberine Alkaloids From Rhizoma Coptidis in HepG2 Cell and Diabetic KK-Ay Mice | Q46568863 |
| | Kinetic difference of berberine between hippocampus and plasma in rat after intravenous administration of Coptidis rhizoma extract | Q46582470 |
| | Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: a mechanism for the action of berberine to activate AMP-activated protein kinase and improve insulin action | Q46745033 |
| | Synthesis and antihyperglycemic evaluation of various protoberberine derivatives | Q46855401 |
| | Berberine ameliorate oxidative stress and astrogliosis in the hippocampus of STZ-induced diabetic rats | Q46914648 |
| | New Insights into the Mechanisms of Chinese Herbal Products on Diabetes: A Focus on the "Bacteria-Mucosal Immunity-Inflammation-Diabetes" Axis. | Q47108560 |
| | Interaction between bone and glucose metabolism [Review]. | Q47718312 |
| | Protective role of berberine and Coptischinensis extract on T2MD rats and associated islet Rin‑5f cells | Q47811968 |
| | The antihypercholesterolemic effect of columbamine from Rhizoma Coptidis in HFHC-diet induced hamsters through HNF-4α/FTF-mediated CYP7A1 activation | Q47853318 |
| | Berberine Improves Diabetic Encephalopathy Through the SIRT1/ER Stress Pathway in db/db Mice | Q47939966 |
| | Influence of quercetin, naringenin and berberine on glucose transporters and insulin signalling molecules in brain of streptozotocin-induced diabetic rats | Q47983181 |
| | Protection of cholinergic and antioxidant system contributes to the effect of berberine ameliorating memory dysfunction in rat model of streptozotocin-induced diabetes | Q48157980 |
| | Dual-target screening of bioactive components from traditional Chinese medicines by hollow fiber-based ligand fishing combined with liquid chromatography-mass spectrometry | Q48757994 |
| | Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort | Q48769554 |
| | Neuroprotective effect of berberine is mediated by MAPK signaling pathway in experimental diabetic neuropathy in rats | Q48925203 |
| | Beneficial effect of berberine on hepatic insulin resistance in diabetic hamsters possibly involves in SREBPs, LXR.ALPHA. and PPAR.ALPHA. transcriptional programs | Q38341518 |
| | Berberine Pretreatment Confers Cardioprotection Against Ischemia-Reperfusion Injury in a Rat Model of Type 2 Diabetes | Q38410398 |
| | Berberine treatment prevents cardiac dysfunction and remodeling through activation of 5'-adenosine monophosphate-activated protein kinase in type 2 diabetic rats and in palmitate-induced hypertrophic H9c2 cells | Q38411498 |
| | Natural Products for the Treatment of Type 2 Diabetes Mellitus | Q38541528 |
| | Comparative pharmacokinetics of six major bioactive components in normal and type 2 diabetic rats after oral administration of Sanhuang Xiexin Decoction extracts by UPLC-TQ MS/MS. | Q38653421 |
| | Prevalence of Gestational Diabetes and Risk of Progression to Type 2 Diabetes: a Global Perspective. | Q38689745 |
| | Berberine Alleviates Oxidative Stress in Islets of Diabetic Mice by Inhibiting miR-106b Expression and Up-Regulating SIRT1. | Q38706356 |
| | α-Glucosidase and α-amylase inhibitors from seed oil: A review of liposoluble substance to treat diabetes | Q38725795 |
| | Berberine induces GLP-1 secretion through activation of bitter taste receptor pathways | Q38849837 |
| | Modifications of dietary flavonoids towards improved bioactivity: An update on structure-activity relationship. | Q38903422 |
| | Coptis chinensis Franch. exhibits neuroprotective properties against oxidative stress in human neuroblastoma cells. | Q38984783 |
| | Effects of high glucose and high insulin concentrations on osteoblast function in vitro | Q38991825 |
| | Berberine, a natural antidiabetes drug, attenuates glucose neurotoxicity and promotes Nrf2-related neurite outgrowth. | Q39108936 |
| | Oxidative stress and diabetic retinopathy: development and treatment | Q39269643 |
| | Coronary microvascular disease as an early culprit in the pathophysiology of diabetes and metabolic syndrome | Q39430910 |
| | Anti-diabetic effect of Coptis Chinensis polysaccharide in high-fat diet with STZ-induced diabetic mice | Q39490230 |
| | Berberine Attenuates Development of the Hepatic Gluconeogenesis and Lipid Metabolism Disorder in Type 2 Diabetic Mice and in Palmitate-Incubated HepG2 Cells through Suppression of the HNF-4α miR122 Pathway | Q28550972 |
| | Chronic effects of berberine on blood, liver glucolipid metabolism and liver PPARs expression in diabetic hyperlipidemic rats | Q28584189 |
| | A metagenome-wide association study of gut microbiota in type 2 diabetes | Q29547726 |
| | Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice | Q29615055 |
| | Oxidative Stress and Diabetic Complications | Q29615423 |
| | Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability | Q29617378 |
| | Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy | Q29620534 |
| | Alkaloids from Coptis chinensis root promote glucose uptake in C2C12 myotubes | Q30738352 |
| | Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults | Q33423654 |
| | 7-Chloroarctinone-b as a new selective PPARgamma antagonist potently blocks adipocyte differentiation | Q33493877 |
| | Elevated Ca2+ sparklet activity during acute hyperglycemia and diabetes in cerebral arterial smooth muscle cells | Q33655566 |
| | Modulation of glucose metabolism by a natural compound from Chloranthus japonicus via activation of AMP-activated protein kinase | Q33677858 |
| | Berberine Ameliorates Diabetes-Associated Cognitive Decline through Modulation of Aberrant Inflammation Response and Insulin Signaling Pathway in DM Rats | Q33766908 |
| | Uncoupling protein-2 mediates the protective action of berberine against oxidative stress in rat insulinoma INS-1E cells and in diabetic mouse islets | Q33842742 |
| | Decreased gastric motility in type II diabetic patients | Q34043578 |
| | Recent advances in the discovery of competitive protein tyrosine phosphatase 1B inhibitors for the treatment of diabetes, obesity, and cancer | Q34087341 |
| | Clinical review 124: Diabetic dyslipidemia: causes and consequences | Q34174659 |
| | Regulation of podocyte survival and endoplasmic reticulum stress by fatty acids | Q34211573 |
| | Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma/stem cells: the role of PPAR-gamma2 transcription factor and TGF-beta/BMP signaling pathways | Q34371949 |
| | Alkaloids as aldose reductase inhibitors, with special reference to berberine | Q34385368 |
| | Berberine reduces fibronectin expression by suppressing the S1P-S1P2 receptor pathway in experimental diabetic nephropathy models | Q34399505 |
| | Update on diabetes classification | Q34451220 |
| | AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle | Q34452979 |
| | Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects | Q34538317 |
| | Berberine inhibits aldose reductase and oxidative stress in rat mesangial cells cultured under high glucose | Q34777983 |
| | Berberine ameliorates renal injury in streptozotocin-induced diabetic rats by suppression of both oxidative stress and aldose reductase. | Q34808178 |
| | Tissue distribution of berberine and its metabolites after oral administration in rats | Q35035856 |
| | Impact of type 2 diabetes and the metabolic syndrome on myocardial structure and microvasculature of men with coronary artery disease | Q35240672 |
| | Pathophysiology of diabetic dyslipidaemia: where are we? | Q35350326 |
| | Endothelial nitric oxide synthase and endothelial dysfunction. | Q35574173 |
| | Transforming berberine into its intestine-absorbable form by the gut microbiota | Q35691271 |
| | Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats | Q35784335 |
| | Berberine inhibits hepatic gluconeogenesis via the LKB1-AMPK-TORC2 signaling pathway in streptozotocin-induced diabetic rats | Q35819543 |
| | Pathogenesis of type 2 diabetes mellitus | Q35861736 |
| | Renoprotective effect of berberine via regulating the PGE2 -EP1-Gαq-Ca(2+) signalling pathway in glomerular mesangial cells of diabetic rats | Q35995332 |
| | Berberine-induced bioactive metabolites of the gut microbiota improve energy metabolism | Q36345197 |
| | Berberine inhibits cardiac fibrosis of diabetic rats | Q51278680 |
| | Coptis chinensis Polysaccharides Inhibit Advanced Glycation End Product Formation. | Q51285749 |
| | Renoprotective effects of berberine through regulation of the MMPs/TIMPs system in streptozocin-induced diabetic nephropathy in rats | Q51299721 |
| | Antidiabetic mechanism of Coptis chinensis polysaccharide through its antioxidant property involving the JNK pathway | Q51305000 |
| | Berberine ameliorates renal injury by regulating G proteins-AC- cAMP signaling in diabetic rats with nephropathy | Q51347304 |
| | Renoprotective effects of berberine and its possible molecular mechanisms in combination of high-fat diet and low-dose streptozotocin-induced diabetic rats | Q51348247 |
| | Effect of linagliptin monotherapy on glycaemic control and markers of β-cell function in patients with inadequately controlled type 2 diabetes: a randomized controlled trial | Q51382786 |
| | The potential beneficial effects of phenolic compounds isolated from A. pilosa Ledeb on insulin-resistant hepatic HepG2 cells | Q51430671 |
| | Effects and underlying mechanism of berberine on renal tubulointerstitial injury in diabetic rats | Q51748373 |
| | Pioglitazone-induced bone loss in diabetic rats and its amelioration by berberine: A portrait of molecular crosstalk. | Q53110705 |
| | Jatrorrhizine hydrochloride attenuates hyperlipidemia in a high-fat diet-induced obesity mouse model | Q53578000 |
| | Berberine, an isoquinoline alkaloid, inhibits streptozotocin-induced apoptosis in mouse pancreatic islets through down-regulating Bax/Bcl-2 gene expression ratio | Q54312577 |
| | BK Channels in the Vascular System | Q54393122 |
| | Attenuation of berberine on lipopolysaccharide-induced inflammatory and apoptosis responses in β-cells via TLR4-independent JNK/NF-κB pathway | Q54399267 |
| | Prorenin, Renin, and their receptor: moving targets | Q54688101 |
| | Berberine ameliorates diabetic nephropathy by inhibiting TLR4/NF-κB pathway. | Q55108878 |
| | Cellular stress response mechanisms of Rhizoma coptidis: a systematic review. | Q55274553 |
| | Poor permeability and absorption affect the activity of four alkaloids from Coptis | Q57106142 |
| | Berberrubine and its analog, hydroxypropyl-berberrubine, regulate LDLR and PCSK9 expression via the ERK signal pathway to exert cholesterol-lowering effects in human hepatoma HepG2 cells | Q58597909 |
| | Restoration of GLP-1 secretion by Berberine is associated with protection of colon enterocytes from mitochondrial overheating in diet-induced obese mice | Q58700647 |
| | The total alkaloids from Franch improve cognitive deficits in type 2 diabetic rats | Q58781641 |
| | Regulation of diabetic cardiomyopathy by caloric restriction is mediated by intracellular signaling pathways involving 'SIRT1 and PGC-1α' | Q58803102 |
| | Molecular Modulation of Osteoblasts and Osteoclasts in Type 2 Diabetes | Q59806788 |
| | Preparation and Evaluation of Antidiabetic Agents of Berberine Organic Acid Salts for Enhancing the Bioavailability | Q61454313 |
| | Coptidis Rhizoma: a comprehensive review of its traditional uses, botany, phytochemistry, pharmacology and toxicology | Q64064784 |
| | Bidirectional regulation of adenosine 5'-monophosphate-activated protein kinase activity by berberine and metformin in response to changes in ambient glucose concentration. | Q64941870 |
| | Diabetes mellitus is associated with insufficient microvascular reperfusion following revascularization for anterior acute myocardial infarction | Q73705940 |
| | GI symptoms in diabetes mellitus are associated with both poor glycemic control and diabetic complications | Q77844995 |
| | A role for beta-cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucose-dependent insulin release | Q79750060 |
| | Berberine potently inhibits protein tyrosine phosphatase 1B: investigation by docking simulation and experimental validation | Q79763647 |
| | Berberine alleviates ischemic arrhythmias via recovering depressed Ito and ICa currents in diabetic rats | Q83089525 |
| | Isoquinoline Alkaloids from Tinospora cordifolia Inhibit Rat Lens Aldose Reductase | Q83372364 |
| | Berberine acutely inhibits the digestion of maltose in the intestine | Q84211238 |
| | Marrow-Derived Cells Regulate the Development of Early Diabetic Retinopathy and Tactile Allodynia in Mice | Q36410673 |
| | Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture). | Q36457102 |
| | Effects and interaction of icariin, curculigoside, and berberine in er-xian decoction, a traditional chinese medicinal formula, on osteoclastic bone resorption. | Q36458647 |
| | Leukocytes regulate retinal capillary degeneration in the diabetic mouse via generation of leukotrienes | Q36476651 |
| | Modulating gut microbiota as an anti-diabetic mechanism of berberine | Q36516516 |
| | Review: Peroxisome proliferator-activated receptor gamma and adipose tissue--understanding obesity-related changes in regulation of lipid and glucose metabolism | Q36674722 |
| | Effect of Berberine on PPARα/NO Activation in High Glucose- and Insulin-Induced Cardiomyocyte Hypertrophy | Q36739688 |
| | Mediator MED23 cooperates with RUNX2 to drive osteoblast differentiation and bone development | Q36768663 |
| | Glucokinase activators for diabetes therapy: May 2010 status report | Q36783849 |
| | Therapy in the Early Stage: Incretins | Q36783865 |
| | Berberine alleviates the cerebrovascular contractility in streptozotocin-induced diabetic rats through modulation of intracellular Ca²⁺ handling in smooth muscle cells | Q36790209 |
| | Berberine improves mesenteric artery insulin sensitivity through up-regulating insulin receptor-mediated signalling in diabetic rats | Q36830141 |
| | Beneficial Effects of Berberine on Oxidized LDL-Induced Cytotoxicity to Human Retinal Müller Cells | Q37126456 |
| | Protective Effects of Berberine on Renal Injury in Streptozotocin (STZ)-Induced Diabetic Mice | Q37210162 |
| | Regulation of SIRT1 by Oxidative Stress-Responsive miRNAs and a Systematic Approach to Identify Its Role in the Endothelium | Q37231719 |
| | Leukocytes from diabetic patients kill retinal endothelial cells: effects of berberine | Q37238931 |
| | Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes | Q37370197 |
| | Berberine protects against palmitate-induced endothelial dysfunction: involvements of upregulation of AMPK and eNOS and downregulation of NOX4. | Q37412690 |
| | Berberine Attenuates Intestinal Mucosal Barrier Dysfunction in Type 2 Diabetic Rats | Q37622726 |
| | Peroxisome proliferator-activated receptor translational research and clinical experience | Q37634781 |
| | In vitro assessment of the glucose-lowering effects of berberrubine-9-O-β-D-glucuronide, an active metabolite of berberrubine | Q37688749 |
| | Immune complex formation in human diabetic retina enhances toxicity of oxidized LDL towards retinal capillary pericytes | Q37716355 |
| | Effect of berberine on the renal tubular epithelial-to-mesenchymal transition by inhibition of the Notch/snail pathway in diabetic nephropathy model KKAy mice | Q37741992 |
| | Müller Glia: A Promising Target for Therapeutic Regeneration | Q37908859 |
| | Two incretin hormones GLP-1 and GIP: comparison of their actions in insulin secretion and β cell preservation. | Q37912391 |
| | Bone, sweet bone--osteoporotic fractures in diabetes mellitus. | Q37976305 |
| | Antidiabetic Properties of Berberine: From Cellular Pharmacology to Clinical Effects | Q38012073 |
| | Mechanisms of diabetic complications. | Q38072902 |
| | An Insight into the Recent Diabetes Trials: What is the Best Approach to Prevent Macrovascular and Microvascular Complications? | Q38122398 |
| | Pathogenesis of diabetic neuropathy: focus on neurovascular mechanisms. | Q38122978 |
| | Diabetes, oxidative stress and therapeutic strategies | Q38218198 |
| | Ca(2+) handling alterations and vascular dysfunction in diabetes | Q38248928 |
| | Screening alpha-glucosidase and alpha-amylase inhibitors from natural compounds by molecular docking in silico | Q38297767 |
| | Berberine-Improved Visceral White Adipose Tissue Insulin Resistance Associated with Altered Sterol Regulatory Element-Binding Proteins, Liver X Receptors, and Peroxisome Proliferator-Activated Receptors Transcriptional Programs in Diabetic Hamsters | Q38335523 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | type 2 diabetes | Q3025883 |
| P304 | page(s) | 805 | |
| P577 | publication date | 2019-07-22 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Frontiers in Pharmacology | Q2681208 |
| P1476 | title | Rhizoma coptidis as a Potential Treatment Agent for Type 2 Diabetes Mellitus and the Underlying Mechanisms: A Review | |
| P478 | volume | 10 | |